China To Launch Biopharma Five-Year Plan; Market To Hit $100 Billion By 2015
This article was originally published in PharmAsia News
China's 12 Five-Year Plan for its biopharma trade is expected to go into effect shortly. The plan aims to have the nation's biomedical market hit $100 billion and have its output reach $200 billion by 2015
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.